Dr. Hochberg joined the faculty of New York Medical College in 2009, and is presently an Assistant Professor of Clinical Pediatrics within the division of Pediatric Hematology, Oncology, and Stem Cell Transplantation. She specializes in hematologic malignancies, tumor lysis syndrome and late effects of cancer therapy. She is currently the Director of the Hematologic Malignancy Program, Director of the Wellness and Survivorship program and Associate Director of the Pediatric Hematology/Oncology Fellowship. She currently serves as the Institutional PI for the Children’s Oncology Group. Dr. Hochberg’s research interests involve development of novel therapeutics and targeted immunotherapy in order to improved outcomes and reduce the burden of traditional chemoradiotherapy in pediatric leukemia and lymphoma.

Office Locations:

Bradhurst

Select Publications

Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children’s Oncology Group Report.Hochberg J, Galardy PJ, Perkins SL, Harrison L, Goldman S, Cairo MS. Br J Haematol. 2013 Nov;163(3):365-72.

Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.Hochberg J, Khaled S, Forman SJ, Cairo MS. Br J Haematol. 2013 Apr;161(1):27-42.

Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions. Hochberg J, Cairo MS. Pediatr Blood Cancer. 2009 Dec;53(6):917-9.

Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Hochberg J, Waxman IM, Kelly KM, Morris E, Cairo MS. Br J Haematol. 2009 Jan;144(1):24-40.

Insight into the biology and treatment of pediatric lymphomas: Clues from international studies.Hochberg J, Cairo MS. Pediatr Blood Cancer. 2009 Feb;52(2):153-4.

Tumor lysis syndrome: current perspective.Hochberg J, Cairo MS. Haematologica. 2008 Jan;93(1):9-13.